Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: Unexpectedly large variation in the gene (sic) encoding a complement- inhibiting protein

Journal of Clinical Microbiology

Volumn 35, Issue 12, 1997, Pages 3220-3224

  Perea Mejia, Luis M ^a   Stockbauer, Kathryn E ^b   Pan, Xi ^b   Cravioto, Alejandro ^a   Musser, James M ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; DNA SEQUENCE; GENETIC VARIABILITY; MEXICO; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A;

BACTERIA (MICROORGANISMS); SPEA; STREPTOCOCCUS GROUP A; STREPTOCOCCUS SP. 'GROUP A';

EID: 0008798773     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.12.3220-3224.1997     Document Type: Article

References (38)

1. Abdalá, A. L., M. C. A. Castañeda, C. N. Gonzalez, A. R. Cárdenas, J. R. Manzur, and L. C. Rodríguez. 1995. Evaluación ecocardiográfica en pacientes con fiebre reumática con corea de Sydenham. Pediatria 62:44-47.
2. Abdalá, A. L., R. Sandoval, L. Lastra, C. Vidales, L. Carbajal, and F. D. Clavijo U. 1980. Comportamiento clínico de 200 casos de fiebre reumática. Acta. Pediatr. Mex. 1:83-89.
3. Akesson, P., A. G. Sjohnlm, and L. Bjorck. 1996 Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 271:1081-1088.
4. Beall, B., R. Facklam, T. Hoenes, and B. Schwartz. 1997. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J. Clin. Microbiol. 35:1231-1235.
5. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
6. Carapetis, J. R., R. Robins-Browne, D. Martin, T. Shelby-James, and G. Hogg. 1995. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin. Infect. Dis. 21:1220-1227.
7. Cockerill, F. R., III, K. L. MacDonald, R. L. Thompson, F. Roberson, P. C. Kohner, J. Besser-Wiek, J. M. Manahan, J. M. Musser, P. M. Schlievert, J. Talbot, B. Frankfort, J. M. Steckelberg, W. R. Wilson, M. T. Osterholm, and the Investigation Team. 1997. An outbreak of severe invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 277:38-43.
8. Dale, J. B., M. Simmons, E. C. Chang, and E. Y. Chang. 1996. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine 14:944-948.
9. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
10. Harbaugh, M. P., A. Podbielski, S. Hugl, and P. P. Cleary. 1993. Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol. Microbiol. 8:981-991.
11. Hauser, A. R., and P. M. Schlievert. 1990. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J. Bacteriol. 172:4536-4542.
12. Jamal, F., S. Pit, D. R. Johnson, and E. L. Kaplan. 1995. Characterization of group A streptococci isolated in Kuala Lumpur, Malaysia. J. Trop. Med. Hyg. 98:343-346.
13. Kaplan, E. L., D. R. Johnson, P. Nanthapisud, S. Sirilertpanrana, and S. Chumdermpadetsuk. 1992. A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications. Bull. W. H. O. 70:433-437.
14. Kapur, V., S. Topouzis, M. W. Majesky, L.-L. Li, M. R. Hamrick, R. J. Hamill, J. M. Patti, and J. M. Musser. 1993. A conserved Streptococcus pyogenes cysteine protease cleaves human fibronectin and degrades vitronectin. Microb. Pathog. 15:327-346.
15. Kehoe, M. A., V. Kapur, A. Whatmore, and J. M. Musser. 1996. Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology. Trends Microbiol. 4:436-443.
16. Levinson, G., and G. A. Gutman. 1987. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol. Biol. Evol. 4:203-221.
17. Loredo-Abdalá, A., J. J. S.-G. De Quevedo, and L. Carbajal-Rodriguez. 1991. Fiebre reumática. Perfil clínico de una enfermedad persistente. Gac. Med. Mex. 127:227-232.
18. Lukomski, S., S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J. M. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99:2574-2580.
19. Martin, D. R., and L. A. Single. 1993. Molecular epidemiology of group A streptococcus M type 1 infections. J. Infect. Dis. 167:1112-1117.
20. Muotiala, A., H. Seppala, P. Houvinen, and J. Vuopio-Varkila. 1997. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J. Infect. Dis. 175:392-399.
21. Musser, J. M. 1997. Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes, p. 281-310. In D. Y. M. Leung, B. T. Huber, and P. M. Schlievert (ed.), Superantigens. Molecular biology, immunology, and relevance to human disease. Marcel Dekker, Inc., New York, N.Y.
22. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.
23. Musser, J. M., V. Kapur, S. Kanjila, U. Shah, D. M. Musher, N. L. Barg, K. H. Johnston, P. M. Schlievert, J. Henrichsen, D. Gerlach, R. M. Rakita, A. Tanna, B. D. Cookson, and J. C. Huang. 1993. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect. Dis. 167:337-346.
24. Musser, J. M., V. Kapur, J. E. Peters, C. W. Hendrix, D. Drehner, G. D. Gackstetter, D. R. Skalka, P. L. Fort, J. T. Maffei, L.-L. Li, and G. P. Melcher. 1994. Real-time molecular epidemiologic analysis of an outbreak of Streptococcus pyogenes invasive disease in US Air Force trainees. Arch. Pathol. Lab. Med. 118:128-133.
25. Musser, J. M., V. Kapur, J. Szeto, X. Pan, D. S. Swanson, and D. R. Martin. 1995. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype Ml protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63:994-1003.
26. Musser, J. M., and R. M. Krause. The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. In R. M. Krause (ed.), Emerging infections, in press. Academic Press, Inc., San Diego, Calif.
27. Mvlvaganam, H., B. Bjorvatn, T. Hofstad, R. Hjetland, E. A. Hoiby, and S. E. Holm. 1994. Small-fragment restriction endonuclease analysis in epidemiologic mapping of group A streptococci. J. Med. Microbiol. 40:256-260.
28. Nelson, K., P. M. Schlievert, R. K. Selander, and J. M. Musser. 1991. Characterization and clonal distribution of four alleles of the speA gene-encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J. Exp. Med. 174:1271-1274.
29. Norgren, M., A. Norrby, and S. E. Holm. 1992. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J. Infect. Dis. 166:1014-1020.
30. Relf, W. A., D. R. Martin, and K. S. Sriprakash. 1992. Identification of sequence types among the M-nontypeahle group A streptococci. J. Clin. Microbiol. 30:3190-3194.
31. Rodriguez, R. S., A. L. Abdala, and A. Vizcaino. 1974. Evaluacion de la paramctasona en la etapa aguda de la carditis reumatica. Bol. Med. Hosp. Infant. Mex. 31:1149-1163.
32. Seppala, H., J. Vuopio-Varkila, M. Osterblad, M. Jakhola, M. Rummukainen, S. E. Holm, and P. Huovinen. 1994. Evaluation of methods for epidemiologic typing of group A streptococci. J. Infect. Dis. 169:519-525.
33. Stockbauer, K. E., D. Grigsby, L. M. Perea Mejia, X. Pan, A. Cravioto, and J. M. Musser. Hypervariability generated by natural selection in an extracellular complement inhibiting protein made by serotype M1 strains of group A streptococcus. Proc. Natl. Acad. Sci. USA, in press.
34. Tran, T. P. O., D. R. Johnson, and E. L. Kaplan. 1991. The presence of M protein in non-typeable group A streptococcal upper respiratory tract (URT) isolates from South-East Asia. J. Infect. Dis. 169:658-661.
35. United States Immigration and Naturalization Service. 1994. Statistical yearbook of the Immigration and Naturalization Service-1993. U.S. Government Publishing Office, Washington, D.C.
36. Upton, M., P. E. Carter, M. Morgan, G. F. S. Edwards, and T. H. Pennington. 1995. Clonal structure of invasive Streptococcus pyogenes in Northern Scotland. Epidemiol. Infect. 115:231-241.
37. Upton, M., P. E. Carter, G. Orange, and T. H. Pennington. 1996. Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland. J. Clin. Microbiol. 34:196-198.
38. Whatmore, A. M., V. Kapur, D. J. Sullivan, J. M. Musser, and M. A. Kehoe. 1994. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol. Microbiol. 14:619-631.